![Tassos Konstantinou](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tassos Konstantinou
Directeur/Membre du Conseil chez Oxford Biotrans Ltd.
Postes actifs de Tassos Konstantinou
Sociétés | Poste | Début | Fin |
---|---|---|---|
Oxford Biotrans Ltd.
![]() Oxford Biotrans Ltd. Chemicals: Major DiversifiedProcess Industries Oxford Biotrans Ltd. develops and commercializes enzymatic process technologies that produce chemical compounds. The firm produces chemicals using ‘green’ biotransformation technology to starting materials into initial focus is on flavors and fragrances using its proprietary understanding of P450 enzyme catalyst technology. The company was founded by Luet Lok Wong in 2013 and is headquartered in Milton Park, the United Kingdom. | Directeur/Membre du Conseil | - | - |
Kynos Therapeutics Ltd.
![]() Kynos Therapeutics Ltd. BiotechnologyHealth Technology Kynos Therapeutics Ltd. develops medicines for therapies. The company is based in Edinburgh, UK. The British company was founded by Damian Mole, Scott Webster. The CEO is Jonathan R. Savidge. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Tassos Konstantinou
Anciens postes connus de Tassos Konstantinou
Sociétés | Poste | Début | Fin |
---|---|---|---|
STORM Therapeutics Ltd.
![]() STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | - | - |
Oxular Ltd.
![]() Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Directeur/Membre du Conseil | - | - |
Formation de Tassos Konstantinou
University of Oxford | Doctorate Degree |
The University of Chicago | Graduate Degree |
Statistiques
Internationale
Royaume-Uni | 6 |
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 4 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Process Industries | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 4 |
---|---|
Oxular Ltd.
![]() Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Oxford Biotrans Ltd.
![]() Oxford Biotrans Ltd. Chemicals: Major DiversifiedProcess Industries Oxford Biotrans Ltd. develops and commercializes enzymatic process technologies that produce chemical compounds. The firm produces chemicals using ‘green’ biotransformation technology to starting materials into initial focus is on flavors and fragrances using its proprietary understanding of P450 enzyme catalyst technology. The company was founded by Luet Lok Wong in 2013 and is headquartered in Milton Park, the United Kingdom. | Process Industries |
STORM Therapeutics Ltd.
![]() STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Kynos Therapeutics Ltd.
![]() Kynos Therapeutics Ltd. BiotechnologyHealth Technology Kynos Therapeutics Ltd. develops medicines for therapies. The company is based in Edinburgh, UK. The British company was founded by Damian Mole, Scott Webster. The CEO is Jonathan R. Savidge. | Health Technology |
- Bourse
- Insiders
- Tassos Konstantinou
- Expérience